CD274 and neoplasm: This is also in line with the observations in the IPI-NIVO-CT arm of the NEOSTAR platform study, but also CheckMate-9LA and CheckMate-227, where the efficacy of IPI-NIVO-CT was irrespective of tumor PD-L1 expression levels.21 24 25